Post Profile






Genomic Sequencing Identifies Mutant 'Drivers' of Common Brain Tumor

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of meningiomas report Dana-Farber Cancer Institute and Broad Institute scientists. Experimental drugs that inhibit these mutant gene pathways are in clinical trials and have shown promising activity.
read more

share

Related Posts


Gene Sequencing Project Discovers Mutations Tied to Deadly Brain Tumors in Young Children

Health : Newswise Medical News

The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified new mutations in pediatric brain tumors known as high-grade gliomas (HGGs), which most often occur in the youngest patien...

Brain Tumors And Other Cancers Identified By Immortality Gene Mutation; Finding Provides New Targets For Drug Development

Health : Medical News Today

Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by ...

Common driver of a childhood brain tumor discovered by gene sequencing project

Health : Medical News Today

The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified the most common genetic alteration ever reported in the brain tumor ependymoma and evidence that the alteration drives tu...

Genomic sequencing identifies mutant 'drivers' of common brain tumor

Academics / General Science : Science Codex

BOSTON—Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report...

Genomic sequencing identifies mutant 'drivers' of common brain tumor

Academics / General Science : ScienceDaily: Science Society

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of meningiomas report scientists. Experimental drugs that inhibit these mutant gene pathways are in clinical trials and have shown p...

Comments


Copyright © 2016 Regator, LLC